TGFBR1*6A is not associated with prostate cancer in men of European ancestry

Prostate Cancer and Prostatic Diseases

Volumn 8, Issue 1, 2005, Pages 50-53

  Suarez, B K ^a   Pal, P ^b   Jin, C H ^a   Kaushal, R ^b   Sun, G ^b   Jin, L ^b   Pasche, B ^c   Deka, R ^b   Catalona, W J ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Association; TGFBR1

Indexed keywords

ALANINE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; ACTIVIN RECEPTOR 1; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; AGE; AGED; ALLELE; ARTICLE; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPE; EXON; FAMILY STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MAXIMUM LIKELIHOOD METHOD; NUCLEOTIDE REPEAT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; CAUCASIAN; GENETIC PREDISPOSITION; GENETICS; PROSTATE TUMOR;

ACTIVIN RECEPTORS, TYPE I; AGED; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 20444497328     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500765     Document Type: Article

References (20)

1. Jemal A et al. Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5-26.
2. Lichtenstein P et al. Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland. N Eng J Med 2000; 343: 78-85.
3. Markowitz S et al. Inactivation of type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995; 268: 1336-1338.
4. Kim IY et al. Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β 1 in human prostate cancer cells. Cancer Res 1996; 56: 44-48.
5. DeCoteau JF et al. Loss of functional cell surface transforming growth factor β (TGF-β) type 1 receptor correlates with insensitivity to TGF-β in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1997; 94: 5877-5881.
6. Chen T, Carter D, Garrigue-Antar L, Reiss M. Transforming growth factor β type 1 receptor kinase mutant associated with metastatic breast cancer. Cancer Res 1998; 58: 4805-4810.
7. Ohwada M et al. Mutational analysis of transforming growth factor β receptor type II and DNA mismatch repair genes in sporadic endometrial carcinomas with microsatellite instability. Oncol Rep 2000; 7: 789-792.
8. Wang D et al. Analysis of specific gene mutations in the transforming growth factor-β signal transduction pathway in human ovarian cancer. Cancer Res 2000; 60: 4507-4512.
9. Baxter SW, Choong DYH, Eccles DM, Campbell IG. Transforming growth factor β receptor 1 polyalanine polymorphism and exon 5 mutation analysis in breast and ovarian cancer. Cancer Epidemiol Biomarkers Prevention 2002; 11: 211-214.
10. Pasche B et al. Type I transforming growth factor β receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer Res 1998; 58: 2727-2732.
11. Pasche B et al. T beta R-I(6A) is a candidate tumor susceptibility allele. Cancer Res 1999; 59: 5678-5682.
12. Samowitz WS, Curtin K, Leppert MF, Slattery ML. Uncommon TGFBRI allele is not associated with increased susceptibility to colon cancer. Genes Chromosome Cancer 2001; 32: 381-383.
13. Kaklamani VG et al. TGFBR1*6A and cancer risk: A meta-analysis of seven case-control studies. J Clin Oncol 2003; 21: 3236-3243.
14. Pasche B et al. TGFBR1*6A and cancer: A meta-analysis of 12 case-control studies. J Clin Oncol 2004; 22: 756-758.
15. Smith DS, Humphrey PA, Catalona WJ. The early detection of prostate carcinoma with prostate specific antigen - The Washington University Experience. Cancer 1997; 80: 1852-1856.
16. Lange K, Weeks D, Boehnke M. Programs for pedigree analysis: MENDEL, FISHER and dGENE. Genet Epidemiol 1988; 5: 471-472.
17. Boehnke M. Allele frequency estimation from data on relatives. Am J Hum Genet 1991; 48: 22-25.
18. Chen T et al. Structural alterations of transforming growth factor-beta receptor genes in human cervical carcinoma. Int J Cancer 1999; 82: 43-51.
19. Van Tilborg AA, de Vries A, Zwarthoff EC. The chromosome 9q genes TGFBR1, TSC1, and ZNF189 are rarely mutated in bladder cancer. J Pathol 2001; 194: 76-80.
20. Wikström P, Bergh A, Damber J-E. Transforming growth factor-β1 and prostate cancer. Scan J Urol Nephrol 2000; 34: 85-94.